Altered Eicosanoid Metabolism in the Cystic Fibrosis Mouse Small Intestine
- 1 October 2008
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 47 (4) , 406-416
Abstract
Objectives: Imbalances in essential fatty acid levels have been reported in cystic fibrosis (CF), which may relate to elevated proinflammatory eicosanoid generation. The aim of this work was to better define eicosanoid metabolism in the CF intestine.Materials and Methods: We used the small intestine of the cystic fibrosis transmembrane conductance regulator knockout mouse (CF mouse) to measure eicosanoid metabolic gene expression by quantitative reverse transcription polymerase chain reaction and Western blot, and eicosanoid levels by enzyme immunoassay, as compared with wild‐type (WT) littermates.Results: In the CF small intestine, expression of the secretory phospholipase A2Pla2g5 mRNA was upregulated to 980% of WT levels. The following were downregulated: leukotriene C4 synthase Ltc4s (mRNA 55% of WT); ω‐hydroxylase cytochrome P450s Cyp2c40 (mRNA 54% of WT), and Cyp4a10 (mRNA 4% of WT); and the major prostaglandin degradative enzymes prostaglandin dehydrogenase Hpgd (mRNA 27% of WT) and leukotriene B4 12‐hydroxydehydrogenase/15‐oxo‐prostaglandin 13‐reductase Ltb4dh (mRNA 64% and protein 30% of WT). The prostaglandins PGE2 and PGF2α were increased to 400% to 600% of WT levels in the CF mouse intestine, and the hydroxyeicosatetraenoic acids (HETEs) 12‐, 15‐, and 20‐HETE were decreased to 3% to 20% of WT levels.Conclusions: There are changes in eicosanoid metabolic gene expression that are accompanied by significant changes in specific eicosanoid levels. These changes are expected to play important roles in the pathophysiology of CF in the intestine.Keywords
Funding Information
- Cystic Fibrosis Foundation (DELISL05G0)
This publication has 65 references indexed in Scilit:
- Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophagesJournal of Cystic Fibrosis, 2008
- Adenosine Regulation of Cystic Fibrosis Transmembrane Conductance Regulator through Prostenoids in Airway EpitheliaAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Association of Cystic Fibrosis with Abnormalities in Fatty Acid MetabolismNew England Journal of Medicine, 2004
- Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosisThe Journal of Pediatrics, 2001
- The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Alters Control of Essential Fatty Acid Utilization in Epithelial CellsThe Journal of Nutrition, 2000
- The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosisPediatric Pulmonology, 1995
- Increase of bradykinin-stimulated arachidonic acid release in a ΔF508 cystic fibrosis epithelial cell lineBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.Proceedings of the National Academy of Sciences, 1986
- Hypothesis RevisitedJournal of Pediatric Gastroenterology and Nutrition, 1984
- Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementationThe American Journal of Clinical Nutrition, 1981